摘要
目的了解合并胃出血的胃溃疡患者使用铝碳酸镁联合奥美拉唑药物进行治疗的临床效果。方法纳入对象来自2015年1月~2017年5月期间收治的合并胃出血症状的胃溃疡患者200例,编序后随机数字表将其分为B组(接受胃溃疡合并胃出血常规对症治疗)与A组(用铝碳酸镁联合奥美拉唑药物治疗),每组100例。比较不同治疗方案下临床治疗效果。结果 A组患者临床疗效显著优于B组(P<0.05);对患者进行平均3个月时间随访,期间A组患者复发例数显著少于B组(P<0.05);疗程期间均无发生严重不良反应(P>0.05)。结论对胃溃疡合并胃出血患者用铝碳酸镁联合奥美拉唑药物进行治疗,能够有效改善相关临床症状,同时对疗程后复发情况有较好的控制效果,安全性高。
Objective To investigate the clinical effect of combined use of hydrotalcite and omeprazole in gastric ulcer patients with gastric bleeding. Methods 200 cases of gastric ulcer with symptoms of stomach bleeding were treated in our hospital from January 2015 to may 2017, and 100 cases in each group were divided into B group （routine treatment ） and A group （Hydrotalcite Combined with Omeprazole treatment based onroutine treatment）. To compare the clinical effect of different treatment schemes. Results The clinical efficacy of A group was significantly higher than that of B group （P 〈0.05）. The average follow-up time was 3 months. After the follow-up time, the number of recurrence cases in group A was significantly less than that in group B（P 〈 0.05）. No serious adverse reaction occurred during the course of treatment （P 〉 0.05）. Conclusion The combination of hydrotalcite combined with omeprazole on gastric ulcer complicated with gastric bleeding can effectively improve the clinical symptoms, and has good control effect on the recurrence after treatment, and is safe and worthy of clinical promotion.
出处
《中国处方药》
2018年第2期61-62,共2页
Journal of China Prescription Drug
关键词
铝碳酸镁
奥美拉唑
胃溃疡
胃出血
Hydrotalcite
Omeprazole
Gastric ulcer
Gastrorrhagia
